Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 21 studies | 56% ± 24% | |
peripheral blood | 17 studies | 42% ± 14% | |
lung | 15 studies | 37% ± 18% | |
eye | 8 studies | 54% ± 23% | |
intestine | 6 studies | 23% ± 5% | |
heart | 6 studies | 47% ± 17% | |
adipose | 5 studies | 44% ± 20% | |
bone marrow | 4 studies | 38% ± 12% | |
lymph node | 4 studies | 35% ± 10% | |
breast | 3 studies | 21% ± 4% | |
uterus | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 7937.15 | 2588 / 2642 | 100% | 50.99 | 704 / 705 |
intestine | 100% | 6668.27 | 964 / 966 | 88% | 12.50 | 464 / 527 |
lung | 100% | 10143.34 | 578 / 578 | 83% | 16.00 | 954 / 1155 |
thymus | 95% | 2991.99 | 623 / 653 | 86% | 16.36 | 522 / 605 |
breast | 99% | 7007.92 | 456 / 459 | 80% | 10.18 | 892 / 1118 |
skin | 81% | 2862.76 | 1468 / 1809 | 97% | 48.06 | 459 / 472 |
prostate | 84% | 2790.11 | 205 / 245 | 79% | 8.23 | 395 / 502 |
ovary | 100% | 8462.43 | 180 / 180 | 55% | 5.04 | 237 / 430 |
stomach | 70% | 3280.81 | 252 / 359 | 82% | 11.50 | 234 / 286 |
bladder | 100% | 5598.14 | 21 / 21 | 47% | 6.34 | 236 / 504 |
esophagus | 88% | 6856.38 | 1278 / 1445 | 56% | 6.26 | 102 / 183 |
uterus | 94% | 4329.25 | 160 / 170 | 46% | 6.21 | 212 / 459 |
adipose | 100% | 9550.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 10006.39 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5647.12 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 15030.60 | 923 / 929 | 0% | 0 | 0 / 0 |
kidney | 18% | 503.73 | 16 / 89 | 80% | 9.60 | 719 / 901 |
heart | 94% | 4725.31 | 806 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 3531.28 | 728 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 22.02 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 76% | 8.63 | 34 / 45 |
pancreas | 4% | 71.73 | 12 / 328 | 68% | 7.99 | 121 / 178 |
adrenal gland | 24% | 438.52 | 62 / 258 | 40% | 3.73 | 91 / 230 |
eye | 0% | 0 | 0 / 0 | 54% | 8.36 | 43 / 80 |
liver | 1% | 23.18 | 2 / 226 | 14% | 1.29 | 55 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0008016 | Biological process | regulation of heart contraction |
GO_0006396 | Biological process | RNA processing |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0090543 | Cellular component | Flemming body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0036002 | Molecular function | pre-mRNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CELF2 |
Protein name | CUGBP Elav-like family member 2 CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3) CUGBP Elav-like family member 2 (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP- and ETR-3-like factor 2) (RNA-binding protein BRUNOL-3) |
Synonyms | ETR3 BRUNOL3 NAPOR CUGBP2 |
Description | FUNCTION: RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in embryonic, but not adult, skeletal muscle. Activates TNNT2 exon 5 inclusion by antagonizing the repressive effect of PTB. Acts both as an activator and as a repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Promotes inclusion of exonS 21 and exclusion of exon 5 of the NMDA receptor R1 pre-mRNA. Involved in the apoB RNA editing activity. Increases COX2 mRNA stability and inhibits COX2 mRNA translation in epithelial cells after radiation injury (By similarity). Modulates the cellular apoptosis program by regulating COX2-mediated prostaglandin E2 (PGE2) expression (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK. Binds to the muscle-specific splicing enhancer (MSE) intronic sites flanking the TNNT2 alternative exon 5. Binds preferentially to UG-rich sequences, in particular UG repeat and UGUU motifs. Binds to apoB mRNA, specifically to AU-rich sequences located immediately upstream of the edited cytidine. Binds AU-rich sequences in the 3'-UTR of COX2 mRNA (By similarity). Binds to an intronic RNA element responsible for the silencing of exon 21 splicing (By similarity). Binds to (CUG)n repeats (By similarity). May be a specific regulator of miRNA biogenesis. Binds to primary microRNA pri-MIR140 and, with CELF1, negatively regulates the processing to mature miRNA . . |
Accessions | ENST00000399850.7 [O95319-2] ENST00000631816.1 ENST00000632065.1 A0A0J9YXJ0 A0A0J9YX66 O95319 ENST00000638035.1 [O95319-2] A0A0J9YXK1 ENST00000542579.5 ENST00000633200.1 V9GY47 ENST00000633077.2 A0A1B0GUN8 V9GYD9 ENST00000637215.1 A0A1B0GU44 ENST00000416382.6 [O95319-1] ENST00000354897.3 ENST00000608830.5 [O95319-5] ENST00000636488.1 ENST00000609692.5 ENST00000631460.1 [O95319-1] E9PC62 Q5VZZ6 ENST00000632728.1 [O95319-2] ENST00000609870.5 ENST00000417956.6 [O95319-2] |